Together, GPR56 expression in TILs reflects a cytotoxic and (pre-)exhausted T cell fraction, which could be of potential interest for targeted reactivation by immunotherapeutic strategies to release their tumor-reactive cytotoxic potential. The gene discussed is ADGRG1; the disease is neoplasm.